{"id":"W3215258031","doi":"10.3390/curroncol28060408","title":"Examining Treatment Patterns and Real-World Outcomes in Chronic Lymphocytic Leukemia Using Administrative Data in Ontario","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; AstraZeneca (Canada); Sunnybrook Health Science Centre","funders":"AstraZeneca; Government of Ontario; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Canadian Institutes of Health Research; AstraZeneca Canada","keywords":"Chemoimmunotherapy; Medicine; Obinutuzumab; Fludarabine; Chlorambucil; Chronic lymphocytic leukemia; Ibrutinib; Cancer registry; Alemtuzumab; Rituximab; Internal medicine; Cyclophosphamide; Population; Cohort; Oncology; Retrospective cohort study; Bendamustine; Cancer; Family medicine; Leukemia; Chemotherapy; Lymphoma; Environmental health; Transplantation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001389,0.000278431,0.0003668246,0.002239133,0.001687597,0.001391648,0.0008809062,0.0002867059,0.001335985],"category_scores_gemma":[0.005510084,0.000339823,0.0005520741,0.008235354,0.0006309087,0.0005453918,0.001117232,0.000442443,0.0001419191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02680518,"about_ca_system_score_gemma":0.02700012,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.9877633,"about_ca_topic_score_gemma":0.9915214,"domain_scores_codex":[0.9980139,0.0002368607,0.0002161851,0.0002895493,0.0006318622,0.0006116881],"domain_scores_gemma":[0.9924746,0.0005539169,0.003524748,0.0003399253,0.002313655,0.0007930113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003704766,0.000009463486,0.9970183,0.00003061755,0.00004370512,0.00002467002,0.0003904954,0.0001078153,0.00005536069,0.00007285219,0.0007676904,0.001441903],"study_design_scores_gemma":[0.000005784408,0.00001070823,0.9976131,0.00002786524,0.0000184448,0.00002917658,0.0007297439,0.0002462456,0.00003361119,0.00001619631,0.001262248,0.000006951564],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9748436,0.0007419581,0.0002086279,0.0004939832,0.000009022669,0.00006353138,0.02172169,0.00001349044,0.001904157],"genre_scores_gemma":[0.9903373,0.0004859344,0.0002445299,0.00009794025,0.000008125213,0.00004673459,0.00843238,0.000005550667,0.0003415364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9877633,"threshold_uncertainty_score":0.1944861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4472185385922062,"score_gpt":0.4972992301964138,"score_spread":0.05008069160420753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}